Tag: Zydus Lifesciences
Zydus Lifesciences acquires 6.5% stake in Mylab via its subsidiary ZAHIL
The acquisition represents collective vision to transform healthcare by combining therapeutic expertise in human formulations and diagnostic capabilities of the two companies
Zydus’s two-dose Covid-19 vaccine, ZyCoV-D receives EUA from DCGI
The two-dose regimen has been approved in the age group of 12 years and above
Zydus subsidiary supported drug data for Menkes disease set to be...
Fortress Biotech and Cyprium Therapeutics alongwith Zydus Lifesciences’ Sentynl Therapeutics announce CUTX-101, copper histidinate data to be presented at 2022 American College of Medical Genetics Annual Clinical Genetics Meeting
Digitalization in pharma operations inevitable but challenges remain: Top CEOs
Industry captains and regulators in the ecosystem deliberate on achieving excellence and quality in operations, vaccine development and sustainability